Believability of real-world evidence (RWE) for informed regulatory decisions

被引：0
|
作者：
Leclerc, Jacinthe [1 ]
Brodovicz, Kimberly G. [2 ]
Chang, Stephen [3 ]
Assimon, Magdalene M. [4 ]
Urushihara, Hisashi [5 ]
Girman, Cynthia J. [6 ]
机构：
[1] Univ Quebec Trois Rivieres, Trois Rivieres, PQ, Canada
[2] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[3] US FDA, Rockville, MD 20857 USA
[4] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[5] Keio Univ, Tokyo, Japan
[6] CERobs Consulting LLC, Chapel Hill, NC USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [1] USE AND POTENTIAL OF REAL-WORLD DATA (RWD) AND REAL-WORLD EVIDENCE (RWE) TO INFORM PRE-MARKET REGULATORY DECISIONS: A SCOPING REVIEW
    Lockhart, C.
    McDermott, C.
    VALUE IN HEALTH, 2023, 26 (12) : S530 - S530
  • [2] The Use of Real-World Evidence for Regulatory Decisions in China
    Xu, Jiayue
    Wu, Wenkai
    Zhang, Xia
    Ren, Yan
    Yao, Minghong
    Liu, Mei
    Zou, Kang
    Wang, Wen
    Sun, Xin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 82 - 95
  • [3] REAL-WORLD EVIDENCE (RWE) TO SUPPORT REGULATORY SUBMISSIONS: LANDSCAPE ASSESSMENT & REVIEW
    Haris, G.
    Acha, V
    Liu, S.
    Burcu, M.
    VALUE IN HEALTH, 2023, 26 (06) : S213 - S213
  • [4] CHALLENGES TO IMPLEMENTING REAL-WORLD EVIDENCE (RWE)
    Vutova, Y.
    Dacheva, A.
    Slavchev, G.
    Djambazov, S.
    VALUE IN HEALTH, 2022, 25 (12) : S367 - S367
  • [5] THE RISE OF REAL-WORLD EVIDENCE (RWE) IN EU MARKETING AUTHORIZATION DECISIONS - PAST, PRESENT, AND FUTURE
    Haas, J.
    Meise, D.
    Braun, S.
    VALUE IN HEALTH, 2022, 25 (12) : S242 - S243
  • [6] REGULATORY VS HTA DIVERGENCES- CAN THE REAL-WORLD EVIDENCE (RWE) BE THE CONNECTING BRIDGE?
    Takyar, J.
    Gil, E.
    Gordon, M.
    Bergemann, R.
    VALUE IN HEALTH, 2024, 27 (06) : S384 - S384
  • [7] Using real-world evidence (RWE) in regulatory decision making: A study of 6 oncology approvals with RWE included in the product label
    Zong, Jihong
    Jiao, Xiaolong
    Pan, Lucy
    Castelo, Sarah
    Campbell, Chelsey
    Lennert, Barb
    Bruno, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness
    Mahendraratnam, Nirosha
    Mercon, Kerra
    Gill, Mira
    Benzing, Laura
    McClellan, Mark B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 150 - 154
  • [9] Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
    Maison, Patrick
    Zureik, Mahmoud
    Hivert, Virginie
    Kjaer, Jesper
    Khonsari, Roman Hossein
    Trifiro, Gianluca
    Ratignier-Carbonneil, Christelle
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] HTA GUIDANCE UPDATES AND USAGE OF REAL-WORLD EVIDENCE (RWE) IN REIMBURSEMENT DECISIONS-A 2023 PERSPECTIVE
    Takyar, J.
    Gordon, M.
    Dhawan, A.
    Pandey, R.
    VALUE IN HEALTH, 2023, 26 (12) : S357 - S357
12345